BIO to host special China Day program.

Press Release Summary:



On June 18, BIO will host China Day program dedicated to exploring questions about changing landscape for innovation, healthcare, and regulatory trends. Event will feature speakers with decades of experience conducting business in Chinese life science sector. Panels will include Healthcare Innovation in China, Developments in the IP Landscape in China, Global Trends in Biologics Regulations, China's Changing Market, and Cross-Border Partnering in Biotechnology.



Original Press Release:



BIO to Host China Day: Biotechnology in the Middle Kingdom: A New Plan, A Renewed Focus, A One Billion Person Promise



2012 BIO International Convention:Biotechnology Industry Organization

WASHINGTON - The Biotechnology Industry Organization (BIO) will host a special China Day program dedicated to exploring questions about the changing landscape for innovation, healthcare reform, global regulatory trends and discuss the right ways to partner at the 2012 BIO International Convention in Boston, Mass.

The event will feature speakers with decades of experience conducting business in the Chinese life science sector. Panels will cover topics such as Healthcare Innovation in China, Developments in the IP Landscape in China, Global Trends in Biologics Regulations, China's Changing Market and Cross-Border Partnering in Biotechnology.

WHO: Li Chen, President & CEO, Hua Medicine

George Baeder, Life Sciences Practice Leader, Monitor Group Shanghai

Helen Chen, Head of China Life Sciences, L.E.K. Consulting

Geoffrey Eich, Executive Director, Biosimilars Strategic Planning & Ops, Amgen

Samir Khalil, Executive Director, Public Policy, Asia Pacific & China, Merck

Richard Kingham, Partner, Covington & Burling LLP

Sandra Dennis, Deputy General Counsel, BIO

Ying Luo, Chairman of the Board, Beijing Continent Pharmaceutical Co., LTD

John F. McDonald, Vice President, Co-Head BD/M&A, Biogen Idec

Xu Ming, Vice President, CCMHPIE

Alexander Natz, Secretary General, EUCOPE

Yinxiang Wang, CEO & CSO, Beta Pharamaceuticals Inc.

Xiaobin Wu, General Manager, Pfizer China

Zegong Zhang, Deputy Director-General, Beijing Pharma and Biotech Center

WHAT: The event will feature substantive panel discussions, a Keynote lunch, featuring several presentations by Chinese bio parks and select members of the Chinese delegation will be invited to tour BIO member company Biogen Idec's Boston facility.

WHERE: BIO International Convention, Boston Convention & Exhibition Center, Room 258A & 259A

WHEN: Monday, June 18, 9:00 am - 6:00 pm

WHY: As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW.

For more information:

Visit www.bio.org

Follow us on Twitter @IAmBiotech

Join us on LinkedIn/MyBio

Become a fan at facebook.com/IAmBiotech

Contacts

Abigail Hirsch, 202-962-9235

ahirsch@bio.org

All Topics